Corvidia Therapeutics to Present on Novel Anti-Inflammatory Therapy for Cardio-Renal Disease at J.P. Morgan Healthcare Conference

WALTHAM, Mass., Jan. 4, 2019 /PRNewswire/ — Corvidia Therapeutics Inc. , a leading clinical stage biotechnology company, will present its work on an investigational cardio-renal therapy being developed to address residual inflammatory cardiovascular risk in patients living with Chronic Kidney Disease...